Keywords
1. Hypermobile Ehlers-Danlos Syndrome
2. Mobility Disability
3. Joint Instability
4. Pain Management
5. Delayed Diagnosis
The chronic and oftentimes debilitating condition known as hypermobile Ehlers-Danlos syndrome (hEDS) has been a source of pain and disability for many, largely due to its elusive nature and the delay in proper diagnosis and management. A recent study published in the journal “Disability and Rehabilitation” sheds new light on key predictors of pain and mobility disability in individuals living with this condition, findings that could have significant implications for treatment and care in the future.
Article DOI: 10.1080/09638288.2019.1608595
Background on Hypermobile Ehlers-Danlos Syndrome:
Hypermobile Ehlers-Danlos Syndrome (hEDS) is a disorder that affects the connective tissues, characterized by symptoms such as extreme flexibility, joint instability, and chronic pain. It is part of a group of disorders known as Ehlers-Danlos Syndromes (EDS), a collection of varying genetic connective tissue disorders. While hEDS is the most common form, it is also difficult to diagnose due to its overlapping symptoms with other conditions.
Summary of the Study
The study conducted by a team led by Larissa Kalisch from the Department of Psychology at Anglia Ruskin University, Cambridge, UK, along with colleagues from France, involved a cross-sectional analysis with the aim of identifying factors that predict the degree of pain and mobility disability experienced by individuals with hEDS.
The study encompassed a sample of adults diagnosed with hEDS. Data were collected on various aspects, including the presence of delayed diagnosis, the extent of joint instability, levels of fatigue, and the severity of pain. The researchers then analyzed the relationships between these factors and the mobility limitations experienced by the participants.
Key Findings
The results of the study were illuminating. A significant correlation was found between the severity of joint instability and the level of pain, providing evidence that joint instability is a considerable contributor to pain in hEDS patients. Moreover, the findings suggested that pain was a major predictor of the degree of mobility disability, indicating that managing pain is critical for improving mobility in hEDS patients.
Another crucial finding was the impact of delayed diagnosis on the participants’ well-being. Those with a prolonged period before receiving an accurate diagnosis of hEDS experienced more intense pain and greater mobility disability, underscoring the importance of early recognition and diagnosis of the disorder.
Implications for Treatment and Support
The conclusions drawn from this study highlight the complexity of managing hypermobile Ehlers-Danlos Syndrome and the necessity for a multifaceted approach that addresses joint instability, pain, and the psychological impact of a delayed diagnosis. Care for individuals with hEDS should not only focus on physical therapy to stabilize joints but also incorporate effective pain management strategies.
Furthermore, the findings emphasize the need for better diagnostic criteria and awareness among healthcare professionals to minimize the delay in diagnosis, which could, in turn, reduce the severity of pain and mobility disability experienced by these patients.
Challenges in Research and Diagnosis
The road to these findings was fraught with challenges. One of them is the heterogeneous nature of hEDS, which complicates the establishment of clear diagnostic criteria. Additionally, because hEDS often mimics other conditions, misdiagnosis is commonplace, leading to delays in appropriate treatment.
There is a need for continuous research to better understand the underlying mechanisms of hEDS and to establish more precise methods for diagnosis and assessment. This would involve refining genetic tests and developing more sensitive clinical evaluations that could detect the disorder early on.
Conclusion
The study by Kalisch and colleagues makes a notable contribution to the understanding of hypermobile Ehlers-Danlos Syndrome. By identifying key predictors of pain and mobility disability, the findings offer a valuable framework for improved treatment and support for individuals affected by this complex condition.
Early and accurate diagnosis, coupled with comprehensive management strategies that target joint instability and pain, could significantly improve the quality of life for those with hEDS. It also paves the way for more research to uncover effective interventions and supportive measures to aid patients in navigating their condition with greater ease and comfort.
Moving forward, there is a clear call to the medical community to enhance recognition of hEDS, sharpen diagnostic skills, and tailor treatment plans to address the unique challenges faced by these patients.
References
1. Kalisch, L., Hamonet, C., Bourdon, C., Montalescot, L., de Cazotte, C., & Baeza-Velasco, C. (2020). Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome. Disability and Rehabilitation, 42(25), 3679-3686. https://doi.org/10.1080/09638288.2019.1608595
2. Castori, M. (2012). Ehlers-Danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations. ISRN dermatology, 2012.
3. Tinkle, B., Castori, M., Berglund, B., Cohen, H., Grahame, R., Kazkaz, H., & Levy, H. (2017). Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175(1), 48-69.
4. Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., … & Tinkle, B. (2017). The 2017 international classification of the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175(1), 8-26.
5. De Wandele, I., Calders, P., Peersman, W., Rimbaut, S., De Backer, T., Malfait, F., & De Paepe, A. (2014). Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls. Seminars in arthritis and rheumatism, 44(3), 353-361.